Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 20 | $153,443 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Jul 2022 16:05 | ZYNE | Zynerba Pharmaceuticals Inc | ANIDO ARMANDO | Chairman & CEO | 19 Jul 2022 | Sale | 11,899 | 1.1 | 13,089 | D |
20 Jul 2022 16:05 | ZYNE | Zynerba Pharmaceuticals Inc | FICKENSCHER JAMES E | Chief Financial Officer | 19 Jul 2022 | Sale | 6,013 | 1.1 | 6,614 | D |
20 Jul 2022 16:06 | ZYNE | Zynerba Pharmaceuticals Inc | ROSENBERGER BRIAN | VP, Commercial & Business Dev. | 19 Jul 2022 | Sale | 4,289 | 1.1 | 4,718 | D |
20 Jul 2022 16:08 | ZYNE | Zynerba Pharmaceuticals Inc | SEBREE TERRI B | President | 19 Jul 2022 | Sale | 8,281 | 1.1 | 9,109 | D |
25 Jan 2023 17:25 | ZYNE | Zynerba Pharmaceuticals Inc | ANIDO ARMANDO | Chairman & Chief Exec. Officer | 23 Jan 2023 | Sale | 35,453 | 0.5978 | 21,194 | D |
25 Jan 2023 17:26 | ZYNE | Zynerba Pharmaceuticals Inc | ROSENBERGER BRIAN | VP, Commercial & Business Dev. | 23 Jan 2023 | Sale | 12,663 | 0.5978 | 7,570 | D |
25 Jan 2023 17:28 | ZYNE | Zynerba Pharmaceuticals Inc | FICKENSCHER JAMES E | Chief Financial Officer | 23 Jan 2023 | Sale | 17,769 | 0.5978 | 10,622 | D |
25 Jan 2023 17:29 | ZYNE | Zynerba Pharmaceuticals Inc | SEBREE TERRI B | President | 23 Jan 2023 | Sale | 24,661 | 0.5978 | 14,742 | D |
17 Feb 2023 16:21 | ZYNE | Zynerba Pharmaceuticals Inc | PARKER ALBERT P | Chief Legal Officer | 15 Feb 2023 | Sale | 3,173 | 0.5418 | 1,719 | D |
15 Jun 2023 16:29 | ZYNE | Zynerba Pharmaceuticals Inc | KISNER DANIEL L | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
15 Jun 2023 16:30 | ZYNE | Zynerba Pharmaceuticals Inc | MOCH KENNETH I | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
15 Jun 2023 16:30 | ZYNE | Zynerba Pharmaceuticals Inc | STEPHENSON PAMELA | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
15 Jun 2023 16:28 | ZYNE | Zynerba Pharmaceuticals Inc | COOPER WARREN D | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
15 Jun 2023 16:28 | ZYNE | Zynerba Pharmaceuticals Inc | BUTLER JOHN P. | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
15 Jun 2023 16:29 | ZYNE | Zynerba Pharmaceuticals Inc | FEDERICI WILLIAM J | Director | 14 Jun 2023 | Sale | 115 | 0.3481 | 40 | D |
14 Sep 2023 16:13 | ZYNE | Zynerba Pharmaceuticals Inc | ANIDO ARMANDO | Chairman & Chief Exec. Officer | 13 Sep 2023 | Sale | 17,830 | 1.3257 | 23,637 | D |
14 Sep 2023 16:13 | ZYNE | Zynerba Pharmaceuticals Inc | JONES KENNETH T | See Remarks | 13 Sep 2023 | Sale | 2,505 | 1.3257 | 3,321 | D |
14 Sep 2023 16:13 | ZYNE | Zynerba Pharmaceuticals Inc | FICKENSCHER JAMES E | Chief Financial Officer | 13 Sep 2023 | Sale | 8,998 | 1.3257 | 11,929 | D |
14 Sep 2023 16:14 | ZYNE | Zynerba Pharmaceuticals Inc | ROSENBERGER BRIAN | VP, Commercial & Business Dev. | 13 Sep 2023 | Sale | 6,411 | 1.3257 | 8,499 | D |
14 Sep 2023 16:14 | ZYNE | Zynerba Pharmaceuticals Inc | SEBREE TERRI B | President | 13 Sep 2023 | Sale | 12,401 | 1.3257 | 16,440 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)